Assignee
CELATOR PHARMACEUTICALS INC
US·20 granted patents·13 pending applications·417 citations·filing 2002–2024
Top patents by PatentIndex Score
33 records- 0197US10058507B2Compositions for delivery of drug combinationsCELATOR PHARMACEUTICALS INC·Filed 2016·Granted Aug 28, 2018·39 cites·20 claims
- 0296US8022279B2Liposomal formulations of anthracycline agents and cytidine analogsCELATOR PHARMACEUTICALS INC·Filed 2005·Granted Sep 20, 2011·60 cites·14 claims
- 0395US10905775B2Particulate constructs for release of active agentsCELATOR PHARMACEUTICALS INC·Filed 2013·Granted Feb 2, 2021·40 cites·8 claims
- 0495US10028912B2Method of lyophilizing liposomesCELATOR PHARMACEUTICALS INC·Filed 2012·Granted Jul 24, 2018·41 cites·18 claims
- 0595US7744921B2Liposome loading with metal ionsCELATOR PHARMACEUTICALS INC·Filed 2007·Granted Jun 29, 2010·53 cites·10 claims
- 0695US7238367B2Liposome loading with metal ionsCELATOR PHARMACEUTICALS INC·Filed 2002·Granted Jul 3, 2007·73 cites·13 claims
- 0794US7850990B2Compositions for delivery of drug combinationsCELATOR PHARMACEUTICALS INC·Filed 2003·Granted Dec 14, 2010·47 cites·13 claims
- 0893US7842676B2Fixed ratio drug combination treatments for solid tumorsCELATOR PHARMACEUTICALS INC·Filed 2006·Granted Nov 30, 2010·51 cites·7 claims
- 0988US11787781B2Inhibiting ataxia telangiectasia and RAD3-related protein (ATR)CELATOR PHARMACEUTICALS INC·Filed 2021·Granted Oct 17, 2023·1 cites·20 claims
- 1086US11583544B2Remote loading of sparingly water-soluble drugs into lipid vesiclesCELATOR PHARMACEUTICALS INC·Filed 2019·Granted Feb 21, 2023·1 cites·18 claims
- 1186US10927418B2Assays and methods for selecting a treatment regimen for a subject with leukemiaCELATOR PHARMACEUTICALS INC·Filed 2016·Granted Feb 23, 2021·3 cites·5 claims
- 1286US10166184B2Method of lyophilizing liposomesCELATOR PHARMACEUTICALS INC·Filed 2018·Granted Jan 1, 2019·4 cites·17 claims
- 1386US2024424007A1Remote loading of sparingly water-soluble drugs into lipid vesiclesCELATOR PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 1486US2025333396A1Inhibiting ataxia telangiectasia and rad3-related protein (atr)CELATOR PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 1584US12070471B2Remote loading of sparingly water-soluble drugs into lipid vesiclesCELATOR PHARMACEUTICALS INC·Filed 2023·Granted Aug 27, 2024·0 cites·15 claims
- 1684US11746386B2Assays and methods for selecting a treatment regimen for a subject with leukemiaCELATOR PHARMACEUTICALS INC·Filed 2021·Granted Sep 5, 2023·1 cites·8 claims
- 1784US10835492B2Method of lyophilizing liposomesCELATOR PHARMACEUTICALS INC·Filed 2018·Granted Nov 17, 2020·1 cites·15 claims
- 1883US11028076B2Inhibiting ataxia telangiectasia and Rad3-related protein (ATR)CELATOR PHARMACEUTICALS INC·Filed 2020·Granted Jun 8, 2021·1 cites·20 claims
- 1982US2023416236A1Inhibiting ataxia telangiectasia and rad3-related protein (atr)CELATOR PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 2075US2023279503A1Assays and methods for selecting a treatment regimen for a subject with leukemiaCELATOR PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 2173US2024366519A1Nanoparticle delivery systemsCELATOR PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 2272US2011223241A1Combination methods and compositionsCELATOR PHARMACEUTICALS INC·Filed 2009·Application pending·0 cites
- 2371US10722464B2Compositions for delivery of drug combinationsCELATOR PHARMACEUTICALS INC·Filed 2018·Granted Jul 28, 2020·0 cites·11 claims
- 2470US10285951B2Nanoparticle delivery systemsCELATOR PHARMACEUTICALS INC·Filed 2016·Granted May 14, 2019·1 cites·15 claims
- 2570US2021169803A1Method of lyophilizing liposomesCELATOR PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 2667US11413253B2Nanoparticle delivery systemsCELATOR PHARMACEUTICALS INC·Filed 2020·Granted Aug 16, 2022·0 cites·15 claims
- 2767US2007148255A1Compositions for delivery of drug combinationsCELATOR PHARMACEUTICALS INC·Filed 2007·Application pending·0 cites
- 2863US12370207B2Low-intensity treatment of hematological disordersCELATOR PHARMACEUTICALS INC·Filed 2021·Granted Jul 29, 2025·0 cites·13 claims
- 2960US2018271787A1Combination methods and compositionsCELATOR PHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
- 3059US2024252522A1Low-intensity treatment of hematological disordersCELATOR PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 3157US2019209484A1Nanoparticle delivery systemsCELATOR PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 3254US2006193902A1Pharmaceutical compositions containing active agents having a lactone group and transition metal ionsCELATOR PHARMACEUTICALS INC·Filed 2004·Application pending·0 cites
- 3352US2016058704A1Platinum drug formulationsCELATOR PHARMACEUTICALS INC·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when CELATOR PHARMACEUTICALS INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →